(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

Weight loss drugs like Ozempic, also known as semaglutide, have become extremely popular in recent years. While it is ...

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Women between the ages of 50 and 64 use medications the most. Nearly 12% of people in the United States have taken GLP-1 medications for weight loss, with usage especially common among women ages 50 ...

Two new studies raise questions about GLP-1 weight-loss drugs and vision risks. While findings show rare links to optic nerve damage and a slight rise in diabetic retinopathy, experts urge caution, ...

The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the ...

NAION is a rare form of vision loss that’s been linked to semaglutide, the active ingredient in Wegovy and Ozempic.

According to NPR, doctors and patients alike have noted the drug has appeared to reduce some people's cravings for booze, ...

GLP-1 drugs suppress appetite and have been shown to reduce calorie intake by up to 800 calories per person per day. GLP-1 ...

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...